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E-mail address: ursula.stochaj@mcgill.ca (U. StochERK and Akt kinases are key components that participate in numerous regulatory processes, includ-
ing the response to stress. Using novel tools for quantitative immunoﬂuorescence, we show that oxi-
dant exposure controls the intracellular activation and localization of ERK1/2 and Akt. Oxidative
stress alters the nuclear/cytoplasmic levels of the kinases, drastically changing phospho-ERK1/2
and phospho-Akt(Ser473) levels in the nucleus. Moreover, pharmacological inhibition of PI3 kinase
modulates the intracellular distribution of phospho-ERK1/2, whereas MEK inhibition affects phos-
pho-Akt(Thr308) and phospho-Akt(Ser473). Our studies identify a new signaling link in the nucleus
of stressed cells, where changes in phospho-ERK1/2 levels correlate directly with changes in phos-
pho-Akt(Ser473).
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Signaling through PI3? Akt and MEK? ERK1/2 modules is
essential for cell growth, proliferation and survival of different
forms of stress. Various stimuli trigger the activation of Akt and
ERK1/2, thereby inducing the phosphorylation of distinct target
molecules located in the cytoplasm and in the nucleus. The speci-
ﬁcity of signaling events not only depends on the activation of ki-
nases, but also on their proper location. This is indicated by the fact
that many kinases, phosphatases and their targets relocate within
the cell upon changes in physiology [1–6]. Activation of the MAP
kinases ERK1/2 by dual phosphorylation (here referred to as p-
ERK1/2) is linked to the nuclear accumulation of the kinases [1].
Full activation of Akt requires the phosphorylation of both
Thr308 and Ser473 (here referred to as p-Akt308 and p-Akt473)
[7–9]. Thr308 is modiﬁed by PDK1; mTORC2 is the most prominent
kinase that phosphorylates Ser473, but other kinases have been
implicated in Ser473 modiﬁcation as well [8–15]. Several publica-
tions suggest that the signaling events and cell type can determine
which kinase phosphorylates Ser473, and some of the pathways
leading to Ser473 phosphorylation are insensitive to PI3 kinase
inhibitors [10–13,15]. Interestingly, recent data demonstrate that
particular pools of activated Akt can be generated in the cytoplasmchemical Societies. Published by E
aj).with regulators that are restricted to this compartment, whereas
unique functions can be attributed to nuclear Akt [16,17].
Upon exposure to certain stimuli and for several types of cancer,
signaling through both PI3 kinase and MEK? ERK modules is acti-
vated simultaneously (reviewed in [18–21]). As the activation of
these two signaling cascades is likely to have different downstream
effects, it is important to regulate the relative input from either path-
way to achieve the appropriate response. This may occur by cross-
talk between both signaling routes [22], adding more complexity to
the spatio-temporal control of signaling. Of particular importance
to the balancing of different signaling cascades and the ultimate
downstream effects is the control of kinase levels in different cellular
compartments, especially in the nucleus and cytoplasm.
Oxidative stress is crucial to human health as it is linked to a
large number of diseases and pathologies, including diabetes, obes-
ity and ischemia/reperfusion injury of the heart and brain [23–25].
In the studies presented here, we used diethyl maleate as an oxi-
dant to analyze in a quantitative fashion the effects on ERK1/2
and Akt activation and localization. Furthermore, with pharmaco-
logical inhibitors of PI3 and MEK-mediated signaling we tested
the hypothesis that interplay between these pathways affects ki-
nase activation and localization. For the experiments described
here, we took advantage of recent developments in imaging and
image-analysis to monitor in a quantitative fashion changes in
ERK1/2 and Akt kinase compartmentalization. The signiﬁcance
of Akt and MEK signaling were monitored by measuring thelsevier B.V. All rights reserved.
Fig. 1. Oxidative stress, PI3 kinase and MEK? ERK signaling alter the localization
of activated ERK1/2. The localization of p-ERK1/2 and t-ERK1/2 was monitored by
indirect immunoﬂuorescence followed by confocal microscopy under the different
conditions shown in the ﬁgure. Pixel intensities in nuclear and cytoplasmic
compartments were quantiﬁed for dually phosphorylated and total ERK1/2. Nuclear
and cytoplasmic ﬂuorescence was quantiﬁed using themultiwavelength cell scoring
module; for each condition the distribution of total and activated kinases was
measured for at least 50 cells. The graphs depict pixel intensities/area. One-way
ANOVA was used for multiple comparisons between all groups, with EtOH/DMSO
treated cells as reference; * indicates P < 0.05. For comparisons of stressed cells,
DEM/DMSO treatment served as reference and # denotes P < 0.05. Size bar is 20 lm.
1988 M. Kodiha et al. / FEBS Letters 583 (2009) 1987–1993nucleocytoplasmic distribution of the transcription factor FoxO3a,
a downstream target of both signaling pathways.
2. Materials and methods
2.1. Growth of cells, stress treatment and incubation with
pharmacological inhibitors
HeLa cells were grown on poly-lysine coated cover slips and
treated with diethyl maleate as described [3]. For treatment with
pharmacological inhibitors, cells were pre-incubated for 1 h with
the solvent DMSO (D), 50 lM LY294002 (LY), 25 lM PD98059
(PD) or a combination of both drugs (Calbiochem) followed by
treatment with ethanol (controls) or 2 mM diethyl maleate (for
4 h at 37 C). DMSO or inhibitors were present throughout the
incubation with the solvent ethanol or DEM. Results were obtained
for at least three independent experiments.
2.2. Antibodies
The following antibodies were used for immunoﬂuorescence: du-
ally phosphorylated ERK1/2 (p-ERK1/2; Cell Signaling, #9106), total
ERK1/2 (t-ERK1/2; StressGen, KAP-MA001C), phosphorylated
Akt-Thr308 (p-Akt308; Cell Signaling, #2965), phosphorylated Akt-
Ser473 (p-Akt473; Santa Cruz Biotechnology, sc-7985), total Akt
(t-Akt; Santa Cruz Biotechnology, sc-1619; Cell Signaling, #9272),
FoxO3a (Cell Signaling; #2497); HuR (Santa Cruz Biotechnology,
sc-5261); rp S6 (Santa Cruz Biotechnology, sc-13007); G3BP (BD
Transduction Laboratories, # 611126). Antibodies were diluted as
recommended by the suppliers. Antibodies against p-Akt308 and
p-Akt473 are likely to recognize Akt independent of the phosphory-
lation state at residue Ser473 or Thr308, respectively. FITC- or
Cy3-labeled secondary antibodies were generated in donkeys
and afﬁnity-puriﬁed to minimize cross-reactivity (Jackson
ImmunoResearch).
2.3. Immunoﬂuorescent staining and confocal microscopy
Established protocols were used for the ﬁxation and permeabi-
lization of cells and incubation with primary and secondary anti-
bodies [5]. Confocal images were collected with a Zeiss LSM510
in the multi-track mode for an optical slice thickness of >0.7 lm.
p-ERK1/2 and t-ERK1/2 were detected with FITC- and Cy3-labeled
secondary antibodies, respectively. Settings for pinhole and detec-
tor gain were identical within each experiment and proper ﬁlters
were used to minimize cross-talk between the channels.
2.4. Quantiﬁcation of ﬂuorescent signals
Quantiﬁcation of pixel intensities in nuclear and cytoplasmic
compartments was as described [5]. In brief, nuclear and cytoplas-
mic ﬂuorescence was measured using the multiwavelength cell
scoring module following recently developed protocols that have
been described in detail [5]. For each condition the distribution
of total and activated kinases was quantiﬁed for at least 50 cells.
Bar graphs in Figs. 1–3 depict pixel intensities/area. Pixel intensi-
ties/area obtained for control conditions (DMSO, EtOH) were de-
ﬁned as 1. All changes in the pixel intensities/area are expressed
relative to the control condition. For example, an increase to 1.6-
fold indicates that the pixel intensity/area is 1.6 times the value
observed in control cells.
2.5. Detection of polyA+ RNA
PolyA+ RNA was localized by hybridization with Cy3-labeled
oligo dT(50) (Gene Link). Control and stressed cells were washedwith PBS and ﬁxed with 3.7% formaldehyde in PBS (15 min, room
temperature), permeabilized in 0.3% Triton-X 100/PBS (10 min,
room temperature) and washed in PBS. Following 15 min incuba-
Fig. 2. The localization of Akt is regulated by oxidative stress as well as signaling through PI3 kinase and MEK? ERK. The levels of nuclear and cytoplasmic p-Akt308, p-
Akt473 and t-Akt were quantiﬁed under different non-stress and stress conditions. The acquisition of confocal images, quantiﬁcation of ﬂuorescence intensities in the nuclear
and cytoplasmic compartments was carried out as described for Fig. 1. Size bar is 20 lm.
M. Kodiha et al. / FEBS Letters 583 (2009) 1987–1993 1989tion in pre-hybridization buffer at 37 C (2 SSC, 20% formamide,
2 mg/ml BSA, 1 mg/ml yeast tRNA), samples were hybridized
overnight at 37 C in pre-hybridization buffer containing 10% dex-
tran sulfate and 1 nmol/ml Cy3-oligo-dT(50). Samples were
washed in 2 SSC, 20% formamide (5 min, 42 C), 2 SSC
(5 min, 42 C), 1 SSC (5 min, room temperature), PBS (5 min,
room temperature), stained with DAPI and mounted in
Vectashield.2.6. Statistical analyses
Data were analyzed by one-way ANOVA to determine differ-
ences among groups. Multiple comparisons were carried out with
control cells (EtOH, DMSO) as reference; * in Figs. 1–3 denotes
P < 0.05. For multiple comparisons among stressed samples, cells
incubated with DEM and DMSO served as reference; for these com-
parisons # indicates P < 0.05.
Fig. 3. The intracellular localization of transcription factor FoxO3a is controlled
by stress and signaling through PI3 kinase and MEK? ERK1/2 pathways. HeLa
cells were treated as in Fig. 1 and images were acquired by high-throughput
screening technology [3,5]. Nuclear and cytoplasmic ﬂuorescence was quantiﬁed
using the MetaXpress multi wavelength cell scoring module; for each condition
FoxO3a distribution was measured for at least 50 cells. Examples of SGs are
marked with arrows; size bar is 20 lm. Note that in stressed cells nuclear
FoxO3a levels are signiﬁcantly different for treatment with LY294002 (DEM/LY)
as compared to the incubation with both LY294002 and PD98059 (DEM/
LY + PD).
1990 M. Kodiha et al. / FEBS Letters 583 (2009) 1987–19933. Results
3.1. Oxidative stress alters the intracellular distribution of ERK1/2 and
phosphorylated Akt
Cell fractionation is frequently used to determine the associa-
tion of proteins with different organelles, a method that is te-
dious and prone to errors, in particular for proteins that bind
to large cellular structures such as the ﬁlament systems. More-
over, procedures required to obtain pure fractions may lead to
artiﬁcial phosphorylation or dephosphorylation of the protein
of interest. Importantly, cell fractionation can not provide infor-
mation on whether a component present in nuclear fractions is
inside the nucleus, bound to the nuclear envelope or associated
with the cytoplasmic side of the nuclear membranes. However,
this knowledge is important to determine whether a kinase can
access its substrates inside the nucleus. This is of particular
interest to the analysis of ERK1/2 and Akt, since these kinases
have numerous targets, in both the nuclear and cytoplasmic
compartments.
To examine the spatial distribution of ERK1/2 and Akt kinases
and detect subtle changes in their localization, we used recently
developed protocols for the quantitative analysis of protein locali-
zation [5]. These procedures combine indirect immunoﬂuores-
cence, confocal imaging and computer-based image-analysis to
measure the intranuclear and cytoplasmic levels of a particular
protein [3–5].
With the immunoﬂuorescence methods described above, the
amounts of p-ERK1/2, t-ERK1/2, p-Akt308, p-Akt473 and t-Akt
were quantiﬁed inside the nucleus and in the cytoplasm. Figs.
1 and 2 show the results for these experiments; the quantiﬁca-
tion is depicted as pixel intensities/area. Results were normal-
ized to non-stress control conditions, which were deﬁned as
1. All the numbers below depict the changes relative to the un-
stressed control. [For example, a 1.6-fold change in the nucleus
denotes that the concentration in the nucleus was 1.6 times the
amount detected in control nuclei; 1.0-fold means that there
was no change relative to the control, and 0.8-fold indicates
that the level decreased to 0.8 of the amount in control cells.]
In response to DEM treatment without kinase inhibitors (Figs. 1
and 2), the levels in nuclei increased signiﬁcantly for p-ERK1/2 (to
1.6-fold, compare samples labeled D/EtOH with D/DEM), p-Akt308
(to 1.5-fold) and p-Akt473 (to 2.3-fold). In the cytoplasm, oxidative
stress elevated the concentration of p-Akt308 (to 1.8-fold), p-
Akt473 (to 1.8-fold) and t-Akt (to 1.8-fold), but not of p-ERK1/2
(1.0-fold) or t-ERK1/2 (to 0.8-fold).
We next tested whether the rise in nuclear p-ERK1/2 and p-Akt
can be attributed to changes in the t-ERK1/2 and t-Akt distribution.
Indeed, stress increased the levels of t-Erk1/2 (to 1.2-fold) and t-
Akt (to 1.3-fold) in nuclei (Figs. 1 and 2). (Note that due to the dif-
ferent volumes of the nuclear and cytoplasmic compartments an
increase in nuclear t-Akt will not lead to the same decrease in cyto-
plasmic levels of the kinase.) These results are consistent with the
interpretation that a portion of ERK1/2 and Akt that was activated
in the cytoplasmmoves to the nucleus following oxidant exposure.
Alternatively, ERK1/2 and Akt may ﬁrst relocate to the nucleus to
become subsequently phosphorylated.
Since the relative abundance of activated kinases in the nucleus
and cytoplasm is likely to impact the endpoint of signaling, we
determined whether their nuclear/cytoplasmic ratio changed in re-
sponse to oxidant exposure (Figs. 1 and 2; bottom panels, nuc/cyt).
This analysis revealed a signiﬁcant rise in the nuclear/cytoplasmic
ratio for p-ERK1/2 (to 1.6-fold), t-ERK1/2 (to 1.45-fold) and p-
Akt473 (to 1.3-fold), whereas a reduction was observed for p-
Akt308 (to 0.9-fold) and t-Akt (to 0.7-fold).
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distribution of kinases in stressed cells
Given that both PI3 kinase and MEK? ERK signaling cascades
were activated by the oxidant DEM, we next tested whether phar-
macological inhibition of PI3 kinase and MEK activation affected
the intracellular distribution of ERK1/2 and Akt. The inhibitors
LY294002 and PD98059, which target PI3 kinase or MEK1/2 and
MEK5, respectively, were used as pharmacological tools to mea-
sure potential changes in the levels of kinases in the nuclear and
cytoplasmic compartments.
Under non-stress conditions, p-Akt308 associates with the plas-
ma membrane where it interacts with cortical F-actin [26, and ref-
erences therein]. Likewise, in our studies p-Akt308 at the cell
periphery partially co-localized with ﬁlamentous actin, as evident
by staining with ﬂuorescently labeled phalloidin (Supplementary
Fig. 1). This partial co-localization was also observed when MEK
signaling was inhibited with PD98059.
In stressed cells, LY294002 elevated the levels of p-ERK1/2 (to
2.1-fold), t-ERK1/2 (to 1.5-fold) and p-Akt473 (to 2.9-fold) in nuclei
of stressed cells, but had a lesser effect on the cytoplasmic kinases
(Figs. 1 and 2, LY/DEM).
A different scenario was observed for theMEK inhibitor PD98059,
which increased p-Akt308 in nuclei (from 1.5-fold upon DEM treat-
ment to 1.9-fold in DEM/ PD98059 incubated cells) and cytoplasm
(from 1.8-fold to 2.6-fold). Interestingly, PD98059 had the opposite
effect on p-Akt473, which decreased in the nuclear compartment of
stressed cells (from 2.3-fold to 1.6-fold), whereas t-ERK1/2 changed
from 1.2-fold to 1.3-fold and t-Akt from 1.3-fold to 0.9-fold. As ex-
pected, PD98059 reduced the levels of p-ERK1/2 in nuclei of stressed
cells. When LY294002 was combined with PD98059, the effect of
MEK inhibition on nuclear p-ERK1/2 and p-Akt473 was at least par-
tially overcome by preventing PI3 kinase activation.
Taken together, our data suggest that PI3 kinase and MEK-
dependent signaling control the distribution of p-ERK1/2, p-
Akt308 and p-Akt473 under stress conditions (Table 1). Results ob-
tained for the combination of PI3 kinase andMEK inhibitors further
substantiate our hypothesis and support the model that these pro-
cesses are controlled by the interplay between different signaling
cascades. In particular, a direct correlation was observed for
changes of p-ERK1/2 and p-Akt473 in the nucleus of stressed cells.
3.3. Effect of Akt and MEK-dependent signaling on the distribution of
FoxO3a
To determine the consequences of stress as well as MEK and PI3
kinase signaling we have chosen FoxO3a, which is an authentic tar-Table 1
Effect of oxidative stress on the nuclear and cytoplasmic levels of ERK1/2, Akt and
FoxO3a. Results for the quantiﬁcation of ﬂuorescence intensities in nuclear (Nuc) and
cytoplasmic (Cyt) compartments of stressed cells are summarized. The distribution of
proteins in DEM-treated cells is compared to unstressed controls. The kinase
concentrations in the nuclear and cytoplasmic compartments of untreated cells are
deﬁned as 1; all changes are expressed relative to the levels in unstressed controls.
+++, increase to 2.1–2.9-fold; ++, increase to 1.5–2.0-fold; +, increase to 1.2–1.4-fold;
+/, 0.8–1.1-fold change in kinase levels. Note that the proﬁle of changes in nuclei is
similar for p-ERK1/2, pAkt-473 and FoxO3a.
Kinase DMSO LY294002 PD98059 LY294002 + PD98059
Nuc Cyt Nuc Cyt Nuc Cyt Nuc Cyt
p-ERK1/2 ++ +/ +++ + + +/ ++ +/
t-ERK1/2 + +/ ++ +/ + +/ + +/
p-Akt308 ++ ++ NA NA ++ +++ NA NA
p-Akt473 +++ ++ +++ ++ ++ ++ +++ ++
t-Akt + ++ +/ + +/ + + ++
FoxO3a ++ + +++ ++ ++ + +++ ++get of both signaling pathways. Members of the forkhead family of
transcription factors (FoxO), such as FoxO3a, are key players in the
regulation of gene expression under various physiological condi-
tions [27,28]. Crucial to the control of FoxO-dependent transcrip-
tion is the proper subcellular localization of FoxO proteins, which
we analyzed here in a quantitative and systematic fashion. Fig. 3
shows FoxO3a distribution in control and stressed cells as well as
the outcome of pharmacological kinase inhibition. In unstressed
cells, the PI3 kinase inhibitor LY294002 increased the amount of
FoxO3a in nuclei to 2.4-fold, whereas the MEK inhibitor PD98059
had no effect. Oxidative stress raised FoxO3a levels in nuclei to
1.5-fold; this was further augmented by PI3 kinase inhibition
which increased nuclear levels to 2.4-fold. Collectively, our data
suggest that activated Akt, known to promote FoxO3a nuclear ex-
port, is the limiting factor for nuclear accumulation of FoxO3a un-
der stress conditions.
Data described above demonstrated cross-talk betweenMEK and
PI3 kinase signaling which regulated the activation and localization
of Akt and ERK1/2. Importantly, this interplay also affected the nucle-
ar accumulation of FoxO3a, but was limited to oxidant-treated cells.
The proﬁle of DEM-induced changes in nuclear FoxO3a levels with or
without kinase inhibitors was similar to those observed for p-Akt473
and p-ERK1/2. Moreover, simultaneous inhibition of PI3 andMEK ki-
nases led to a statistically signiﬁcant reduction of FoxO3a levels in
nuclei when compared to PI3 kinase inhibition only (P < 0.05; multi-
ple comparisons among DEM-treated cells with DEM/LY294002 as
reference). Taken together, this suggests that PI3 kinase is the most
important factor determining FoxO3a localization under normal
and stress conditions, whereas signaling through MEK is not a limit-
ing factor under non-stress conditions. However, in stressed cells and
in the absence of PI3 kinase activation, MEK signaling contributes to
FoxO3a distribution as well.
Surprisingly, DEM treatment not only changed the nuclear con-
centration of FoxO3a, but also altered its distribution in the cyto-
plasm, where FoxO3a became associated with granules (Fig. 3;
arrows). Many forms of stress cause the formation of cytoplasmic
stress granules (SGs), compartments that contain mRNA, RNA-
binding and small ribosomal subunit proteins [29]. Indeed, follow-
ing DEM incubation FoxO3a co-localized with HuR, G3BP1 and
ribosomal protein S6 in cytoplasmic SGs, which were also enriched
for polyA+ RNA (Supplementary Fig. 2), suggesting a possible role
for FoxO3a in the cytoplasm. In this scenario, the proper balance
between nuclear and cytoplasmic levels would be important for
FoxO3a functioning in both compartments, and we calculated the
nuclear/cytoplasmic ratios for all experimental conditions (Fig. 3;
bottom panels; nuc/cyt). The ratio was somewhat increased by
stress (to 1.2-fold), but the most pronounced change was seen in
unstressed cells following the inhibition of PI3 kinase (to 2.1-fold)
or of both PI3 kinase and MEK (to 2.3-fold).
Collectively, our results demonstrate that PI3 kinase signaling is
the most important component that determines FoxO3a localiza-
tion. Nevertheless, upon oxidative stress, but not in unstressed
cells, the nucleocytoplasmic FoxO3a distribution is also regulated
by an interdependent network of PI3 kinase and MEK signaling.
Moreover, our data show, for the ﬁrst time, that oxidant treatment
triggers the association of FoxO3a with cytoplasmic stress
granules.
4. Discussion
With the experiments described here we advanced the under-
standing of the complex regulatory mechanisms that underlie the
localized action of signaling events. To our knowledge, this is the
ﬁrst study that applies newly developed methods in confocal
microscopy combined with computer-based image-analysis to
provide a quantitative investigation of the activation and localiza-
Fig. 4. Simpliﬁed model for stress-induced changes in the distribution of p-ERK1/2,
p-Akt473 and FoxO3a. Arrows indicate changes in the nuclear levels of p-ERK1/2, p-
Akt473 and FoxO3a. Protein kinase inhibition reveals that in stressed cells cross-
talk between PI3 kinase and MEK pathways controls the nucleocytoplasmic
distribution of p-ERK1/2 and p-Akt473. Moreover, FoxO3a association with
different cellular compartments depends on oxidant exposure and kinase activa-
tion. Overall, the model proposes that compartmental changes in p-ERK1/2 and p-
Akt473 kinase levels, together with cross-talk between both signaling modules,
may modulate the nucleocytoplasmic distribution of numerous target molecules,
including FoxO3a.
1992 M. Kodiha et al. / FEBS Letters 583 (2009) 1987–1993tion of Akt and ERK1/2 kinases under normal and oxidative stress
conditions. Our research tested the hypothesis that oxidative stress
alters the subcellular distribution of these kinases, possibly gener-
ating speciﬁc pools of signal transducers that may determine the
end-point result of signaling events. Furthermore, we demonstrate
that PI3 kinase activation affects MEK-dependent processes and
vice versa, in line with the idea that interplay between both path-
ways participates in the control of signaling in response to oxidant
exposure. At the molecular level, several mechanisms will contrib-
ute to the steady-state distribution of Akt, ERK1/2 and their target
FoxO3a. This includes the modiﬁcation by upstream kinases or
phosphatases, trafﬁcking in and out of the nucleus as well as reten-
tion in the nuclear or cytoplasmic compartment. The simpliﬁed
model shown in Fig. 4 depicts the stress-induced changes for p-
ERK1/2, p-Akt473 and the transcription factor FoxO3a, showing
that these changes were distinct in the nuclear and cytoplasmic
compartments. In particular, in stressed cells a striking correlation
was detected between nuclear p-ERK1/2 and p-Akt473 levels, indi-
cating that signaling in the nucleus through both pathways is
linked. These results suggest that in oxidant-treated cells PI3 ki-
nase and MEK? ERK1/2 signaling are interdependent events.
Thus, inhibition of PI3 kinase signaling not only promotes ERK1/2
activation; it also leads to phosphorylation of Akt on Ser473.
It should be noted that in stressed cells treatment with
LY294002 was able to override completely the effect of PD98059
for nuclear p-Akt473, but only partially for nuclear p-ERK1/2. The
reasons for this difference are not understood, but as a conse-
quence the nuc/cyt ratio was lower for p-ERK1/2 than for p-
Akt473. Different not mutually exclusive scenarios may explain
these results. For instance, MEK activity in cells treated with both
inhibitors may be sufﬁcient to generate p-Akt473 to an extent sim-ilar to LY294002-treated cells. Alternatively, other factors that
determine the amount of p-Akt473 and p-ERK1/2 in nuclei may re-
spond differently to the simultaneous addition of LY294002 and
PD98059. Possible candidates are one or more of the phosphatases
that regulate the levels of p-Akt473 or p-ERK1/2 [30–32].
Interestingly, in our studies PI3 kinase inhibition had distinct
effects on Thr308 and Ser473 modiﬁcation of Akt, which may be
explained by the complex regulation of Akt phosphorylation.
Whereas PDK1, a downstream target of PI3 kinase, phosphory-
lates Thr308, different pathways are implicated in the modiﬁca-
tion of Ser473, some of which are insensitive to inhibitors of PI3
kinase [8–15]. Based on the results described here we propose
that PI3 kinase independent signaling plays a major role in mod-
ifying this Ser473 in our experimental settings, leading to an in-
crease in Ser473 phosphorylation when Thr308 modiﬁcation is
abolished.
The cross-talk identiﬁed by us is likely to have intricate conse-
quences for signal transduction. For instance, Ser473 phosphoryla-
tion of Akt is believed to stabilize the active conformation of the
kinase [8], and p-Akt308 may differ in substrate speciﬁcity from
Akt dually modiﬁed on Thr308 and Ser473 [8,9]. As such, Akt phos-
phorylated on both Thr308 and Ser473 seems to favor pro-survival
signaling, in part by promoting FoxO phosphorylation in the nu-
cleus [9]. In addition to the phosphorylation of Akt on Thr308
and Ser473, the appropriate nucleocytoplasmic distribution of
the kinase will be crucial for downstream events. The proper local-
ization will affect the phosphorylation not only of nuclear targets,
but of cytoplasmic substrates as well. These cytoplasmic targets in-
clude, but are not limited to, components that modulate the orga-
nization and functions of the cytoplasmic compartment, such as
actin and proteins involved in translational control.
The principles described for PI3 kinase inhibition also apply to
signaling through MAPKs, and it is noteworthy that MEK inhibition
altered the levels of p-Akt308 and p-Akt473 in stressed cells. Spe-
ciﬁcally, PD98059 increased the concentration of p-Akt308 in both
nuclei and cytoplasm, whereas the amount of p-Akt473 in nuclei
was reduced under stress and normal conditions. These observa-
tions indicate that MEK activities impinge differently on the phos-
phorylation of Akt residues 308 and 473, adding further
complexity to the interplay between PI3 and MEK1/2 and MEK5
signaling pathways, consistent with reports that suggested cross-
talk between Raf and Akt signaling [22]. However, data presented
here go beyond previous studies as they provide a quantitative
analysis of this interplay between Akt and ERK1/2 signaling events
by measuring the compartment-speciﬁc changes in kinase distri-
bution. This enabled us to identify a new link in the nucleus be-
tween p-ERK1/2 and p-Akt473. Recent studies by others
demonstrate the importance of Akt signaling in the cytoplasm to
achieve a speciﬁc physiological response [16]. Our data now pro-
vide evidence for speciﬁc signaling events and interplay between
signaling cascades that are located in the nuclear compartment
and are likely to impact numerous nuclear processes.
In conclusion, on the basis of the results described here, we pro-
pose that upon oxidative stress, signaling through PI3 kinase and
MEK occurs in an interdependent fashion. The balance between
both pathways will be critical to deﬁne the endpoint of the cellular
response and ultimately the survival under oxidative stress
conditions.Acknowledgments
This research was supported by grants from CIHR, NSERC and
HSFQ to US. MK is a recipient of a fellowship from the Heart and
Stroke Foundation of Canada and PB is supported by a fellowship
from FRSQ/Heart and Stroke Foundation of Canada.
M. Kodiha et al. / FEBS Letters 583 (2009) 1987–1993 1993Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2009.05.011.
References
[1] Chambard, J., Leﬂoch, R., Pouysségur, J. and Lenormand, P. (2007) ERK
implication in cell cycle regulation. Biochim. Biophys. Acta 1773, 1299–1310.
[2] Lawrence, M.C., Jivan, A., Shao, C., Duan, L., Goad, S., Zaganjor, E., Osborne, J.,
McGlynn, K., Stippec, S., Earnest, S., Chen, W. and Cobb, M.D. (2008) The roles
of MAPKs in disease. Cell Res. 18, 436–442.
[3] Kodiha, M., Rassi, J.G., Brown, C.M. and Stochaj, U. (2007) Localization of AMP
kinase is regulated by stress, cell density, and signaling through the
MEK? ERK1/2 pathway. Am. J. Physiol. Cell Physiol. 293, 1427–1436.
[4] Kodiha, M., Ban´ski, P., Ho-Wo-Cheong, D. and Stochaj, U. (2008) Dissection of
the molecular mechanisms that control the nuclear accumulation of transport
factors importin-a and CAS in stressed cells. Cell Mol. Life Sci. 65, 1756–1767.
[5] Kodiha, M., Brown, C.M. and Stochaj, U. (2008) Analysis of signaling events by
combining high throughput screening technology with computer based image
analysis. Sci. Signal. 1, 12.
[6] Turjanski, A.G., Vaqué, J.P. and Gutkind, J.S. (2007) MAP kinases and the control
of nuclear events. Oncogene 26, 3240–3253.
[7] Franke, T.F. (2007) Intracellular signaling by Akt: bound to be speciﬁc. Sci.
Signal. 1, 29.
[8] Franke, T.F. (2008) PI3K/Akt: getting it right matters. Oncogene 27, 6473–
6488.
[9] Sale, E.M. and Sale, G.J. (2008) Protein kinase B: signalling roles and
therapeutic targeting. Cell Mol. Life Sci. 65, 113–127.
[10] Konishi, H., Matsuzaki, H., Tanaka, M., Ono, Y., Tokunaga, C., Kuroda, S. and
Kikkawa, U. (1996) Activation of RAC-protein kinase by heat shock and
hyperosmolarity stress through a pathway independent of
phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. USA 93, 7639–7643.
[11] Sable, C.L., Filippa, N., Hemmings, B. and Van Obbergen, O.E. (1997) cAMP
stimulates protein kinase B in a wortmannin-insensitive manner. FEBS Lett.
409, 253–257.
[12] Mao, K., Kobayashi, S., Jaffer, Z.M., Huang, Y., Volden, P., Chernoff, J. and Liang,
Q. (2008) Regulation of Akt/PKB activity by p21-activated kinase in
cardiomyocytes. J. Mol. Cell Cardiol. 44, 429–434.
[13] Feng, J., Park, J., Cron, P., Hess, D. and Hemmings, B.A. (2004) Identiﬁcation of a
PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase.
J. Biol. Chem. 279, 41189–41196.
[14] Dong, L.Q. and Liu, F. (2005) PDK2: the missing piece in the receptor tyrosine
kinase signaling pathway puzzle. Am. J. Physiol. Endocrinol. Metab. 289,
E187–E196.[15] Kawakami, Y., Nishimoto, H., Kitaura, J., Maeda-Yamamoto, M., Kato, R.M.,
Littman, D.R., Leitges, M., Rawlings, D.J. and Kawakami, T. (2005) Protein
kinase C bII regulates Akt phosphorylation on Ser-473 in a cell type- and
stimulus-speciﬁc fashion. J. Biol. Chem. 279, 47720–47725.
[16] Vereshchagina, N., Ramel, M., Bitoun, E. and Wilson, C. (2008) The protein
phosphatases PP2A-B’ subunit Widerborst is a negative regulator of
cytoplasmic activated Akt and lipid metabolism in Drosophila. J. Cell Sci.
121, 3383–3392.
[17] Miyamoto, S., Rubio, M. and Sussman, M.A. (2009) Nuclear and mitochondrial
signalling Akts in cardiomyocytes. Cardiovasc. Res. doi:10.1093/cvr/cvp087.
[18] Meier, F., Schittek, B., Busch, S., Garbe, C., Smalley, K., Satyamoorthy, K., Li, G.
and Herlyn, M. (2005) The Ras/Raf/MEK/ERK and PI3K signaling pathways
present molecular targets for the effective treatment of advanced melanoma.
Frontiers Biosci. 10, 2986–3001.
[19] Henson, E.S. and Gibson, S.B. (2006) Surviving cell death through epidermal
growth factor (EGF) signal transduction pathways: implications for cancer
therapy. Cell Signal. 18, 2089–2097.
[20] Rozengurt, E. (2007) Mitogenic signaling pathways induced by G protein-
coupled receptors. Cell Physiol. 213, 589–602.
[21] Fischer, P. and Hilﬁker-Kleiner, D. (2007) Survival pathways in hypertrophy
and heart failure: the gp130-STAT3 axis. Basic Res. Cardiol. 102, 393–411.
[22] Zimmermann, S. and Moelling, K. (1999) Phosphorylation and regulation of
Raf by Akt (protein kinase B). Science 286, 1741–1744.
[23] Lawlor, M.A. and Alessi, D.R. (2001) PKB/Akt: a key mediator of cell
proliferation, survival and insulin responses? J. Cell Sci. 114, 2903–2910.
[24] Avogaro, A., Kreutzenberg, S. and Fadini, G. (2008) Oxidative stress and
vascular disease in diabetes: Is the dichotomization of insulin signaling still
valid? Free Rad. Biol. Med. 44, 1209–1215.
[25] Forbes, J.M., Coughlan, M.T. and Cooper, M.E. (2008) Oxidative stress as a
major culprit in kidney disease in diabetes. Diabetes 57, 1446–1454.
[26] Vandermoere, F., Yazidi-Belkoura, I.E., Demont, Y., Slomianny, C., Antol, J.,
Lemoine, J. and Hondermarck, H. (2007) Proteomics exploration reveals that
actin is a signaling target of the kinase Akt. Mol. Cell Proteom. 6, 114–124.
[27] Huang, H. and Tindall, D.J. (2007) Dynamic FoxO transcription factors. J. Cell
Sci. 120, 2479–2487.
[28] Calnan, D.R. and Brunet, A. (2008) The FoxO code. Oncogene 27, 2276–2288.
[29] Anderson, P. and Kedersha, N. (2008) Stress granules: the Tao of RNA triage.
Trends Biol. Sci. 33, 141–150.
[30] Brognard, J., Sierecki, E., Gao, T. and Newton, A.C. (2007) PHLPP and a second
isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by
regulating distinct Akt isoforms. Mol. Cell 25, 917–931.
[31] Yoon, S. and Seger, R. (2006) The extracellular signal-regulated kinase:
multiple substrates regulate diverse cellular functions. Growth Factors 24,
21–44.
[32] Owens, D.M. and Keyse, S.M. (2007) Differential regulation of MAP kinase
signaling by dual-speciﬁcity protein phosphatases. Oncogene 26, 3203–
3213.
